Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.300
+0.100 (4.55%)
Dec 2, 2025, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 718.4 million as of December 2, 2025. Its market cap has decreased by -1.17% in one year.
Market Cap
718.40M
Enterprise Value
108.82M
Revenue
73.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 718.40M, a decrease of -86.99%. That is a compound annual growth rate of -29.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 718.40M | -27.77% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.59B |
| Nordhealth AS | 2.88B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.58B |
| ArcticZymes Technologies ASA | 1.15B |
| Omda AS | 955.66M |
| Vistin Pharma ASA | 886.89M |
| Gentian Diagnostics ASA | 829.72M |